| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,883 |
9,129 |
$1.32M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,490 |
6,934 |
$682K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,188 |
1,582 |
$169K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,051 |
1,552 |
$168K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,711 |
1,107 |
$128K |
| 99401 |
|
5,805 |
2,706 |
$117K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,688 |
1,030 |
$111K |
| 92552 |
|
5,589 |
3,875 |
$96K |
| D1206 |
Topical application of fluoride varnish |
2,726 |
2,677 |
$68K |
| 99215 |
Prolong outpt/office vis |
519 |
242 |
$49K |
| 90686 |
|
2,352 |
1,700 |
$39K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,786 |
3,736 |
$38K |
| 94010 |
|
1,386 |
943 |
$27K |
| 96127 |
|
10,854 |
5,108 |
$25K |
| 96160 |
|
16,822 |
8,000 |
$23K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
2,270 |
1,110 |
$20K |
| 3074F |
|
3,044 |
2,020 |
$17K |
| 3078F |
|
3,043 |
2,027 |
$17K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
986 |
720 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,732 |
523 |
$14K |
| 90648 |
|
956 |
622 |
$14K |
| 99173 |
|
5,804 |
4,020 |
$10K |
| 94760 |
|
9,924 |
5,786 |
$10K |
| 90670 |
|
573 |
415 |
$9K |
| 92567 |
|
641 |
476 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,393 |
625 |
$9K |
| 81002 |
|
3,854 |
2,616 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
321 |
156 |
$7K |
| 96161 |
|
4,113 |
2,517 |
$7K |
| 90723 |
|
531 |
279 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
307 |
291 |
$5K |
| 94664 |
|
650 |
351 |
$5K |
| 90680 |
|
459 |
217 |
$5K |
| 90677 |
|
387 |
206 |
$5K |
| 90656 |
|
283 |
198 |
$4K |
| A7005 |
Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable |
323 |
86 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
62 |
53 |
$3K |
| 99051 |
|
402 |
142 |
$3K |
| 99070 |
|
1,066 |
723 |
$2K |
| 90480 |
|
86 |
42 |
$1K |
| 0072A |
|
33 |
33 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
500 |
86 |
$1K |
| 90734 |
|
45 |
37 |
$814.80 |
| 0071A |
|
16 |
16 |
$642.06 |
| 90651 |
|
29 |
28 |
$605.27 |
| A7015 |
Aerosol mask, used with dme nebulizer |
322 |
86 |
$582.32 |
| 90620 |
|
33 |
26 |
$582.00 |
| 0003A |
|
13 |
13 |
$520.00 |
| 0001A |
|
22 |
13 |
$520.00 |
| 90633 |
|
37 |
16 |
$279.36 |
| 0124A |
|
29 |
14 |
$240.00 |
| J7510 |
Prednisolone oral, per 5 mg |
69 |
30 |
$70.98 |
| 99000 |
|
4,288 |
2,446 |
$46.09 |
| 99072 |
|
1,171 |
717 |
$26.28 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
319 |
85 |
$17.73 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
211 |
25 |
$14.72 |
| G9920 |
Screening performed and negative |
600 |
326 |
$0.00 |
| 91312 |
|
29 |
14 |
$0.00 |
| 91300 |
|
89 |
72 |
$0.00 |
| 90661 |
|
345 |
60 |
$0.00 |
| G9521 |
Total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months |
979 |
538 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,516 |
1,304 |
$0.00 |
| G9432 |
Asthma well-controlled based on the act, c-act, acq, or ataq score and results documented |
978 |
536 |
$0.00 |
| 91307 |
|
178 |
61 |
$0.00 |